Identification of CTHRC1 as a novel candidate for neurodevelopmental disorders
{{output}}
Background: Cognitive dysfunction affects over 50 million individuals worldwide, with Alzheimer's disease (AD) representing two-thirds of cases. We identified CTHRC1 (Collagen Triple Helix Repeat Containing 1) as a novel candida... ...
